Vaishali Pharma - Quaterly Results

10 Nov 2021 Evaluate
The Top line for the quarter ended September 2021 of Rs. 198.61 millions up 98.02% from Rs. 100.30 millions.Net profit for the quarter ended September 2021 increased significantly by 81.58% to Rs. 14.00 millions from Rs. 7.71 millions.Operating profit for the quarter ended September 2021 rose to 25.80 millions as compared to 16.60 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 198.61 100.30 98.02 281.31 135.96 106.91 537.74 600.86 -10.50
Other Income 3.65 3.73 -2.14 9.32 9.15 1.86 18.09 21.73 -16.75
PBIDT 25.80 16.60 55.42 44.17 22.10 99.86 44.41 29.98 48.13
Interest 6.11 5.13 19.10 12.63 9.57 31.97 26.11 24.81 5.24
PBDT 19.69 11.47 71.67 31.54 12.53 151.72 18.30 5.17 253.97
Depreciation 1.02 1.05 -2.86 2.04 2.08 -1.92 4.27 4.38 -2.51
PBT 18.67 10.42 79.17 29.50 10.45 182.30 14.03 0.79 1675.95
TAX 4.67 2.71 72.32 7.38 2.72 171.32 3.58 0.46 678.26
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.21 -0.10 110.00
PAT 14.00 7.71 81.58 22.12 7.73 186.16 10.45 0.33 3066.67
Equity 105.46 105.46 0.00 105.46 105.46 0.00 105.46 105.46 0.00
PBIDTM(%) 12.99 16.55 -21.51 15.70 16.25 -3.40 8.26 4.99 65.52
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.